https://www.thebodypro.com/category/hiv-prevention-methods/tag/interviews

The Latest

doctor talking to unrecognizable patient

For PrEP to Work, Shared Doctor-Patient Decision-Making Is Key

The process of choosing between PrEP options is often not straightforward. Oni Blackstock, M.D., explains how providers can help ensure their patients end up with the most successful option for them.

By Terri Wilder, M.S.W.
intimate

Understanding U=U Can Improve Health Outcomes for People Living with HIV—but the Message Matters

W. David Hardy, M.D., discusses the takeaway messages for HIV care providers after a recent research paper found that a third of all people living with HIV reported never discussing U=U with their provider.

By Terri Wilder, M.S.W.
Juan Berenguer, M.D., Ph.D. and Antonio Urbina, M.D.

Immediate HIV Treatment Initiation With Integrase Inhibitors Leads to Large Drop in Secondary HIV Transmission Among MSM

Integrase inhibitors are known to be potent first-line therapy options. Recent research suggests their benefits extend to onward HIV prevention as well.

By Terri Wilder, M.S.W. and Myles Helfand
Annette Gaudino and Bryn Gay

With Several Curative Therapies for Hepatitis C on the Market, the Research Pipeline for Prevention Continues

The authors of an influential annual report on hepatitis C research and development talk through what's new and evolving in clinical science.

By Terri Wilder, M.S.W.
Zeda Rosenberg and Manju Chatani

A Vaginal Ring to Prevent HIV Was Given a Positive Opinion by a European Drug Regulator. Here’s What You Need to Know About It.

Two experts discuss the history of the ring, how it works, and when it may come to the United States.

By Terri Wilder, M.S.W.
busy hospital

To Increase Access to HIV Post-Exposure Prophylaxis, New York State Updated Its Guidelines for Clinicians

If you’re a provider in or outside the state, you’ll want to read these new guidelines.

By Terri Wilder, M.S.W.
injectable

What Are the New HIV Treatment and Prevention Drugs Under Development in 2020?

Richard Jefferys of Treatment Action Group discusses the pipeline for new modalities being explored for treatment, PrEP, vaccine, and cure.

By Terri Wilder, M.S.W.
Lynne Mofenson

After Years of Decline, Perinatal HIV Transmission Has Hit a Plateau. Why?

This researcher has some ideas about what we need to do to address the problem.

By Terri Wilder, M.S.W.
cisgender woman prescription

Evaluating PrEP Uptake and Adherence in Cisgender Women—and What to Do About It

Two researchers discuss their analysis of Philadelphia FIGHT’s HIV pre-exposure prophylaxis (PrEP) program for cisgender women.

By Terri Wilder, M.S.W.
Governor Brian Kemp

Governor Brian Kemp’s COVID-19 Response Has Georgia On This HIV Doctor's Mind

Dr. Melanie Thompson discusses what’s happening in the state around coronavirus, and what it means for people living with HIV.

By Terri Wilder, M.S.W.